Shares of HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $111.7857.
A number of research firms have weighed in on HQY. BTIG Research decreased their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Raymond James Financial set a $100.00 target price on HealthEquity in a research note on Tuesday, February 17th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their target price for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Barclays reduced their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd.
Check Out Our Latest Report on HQY
Hedge Funds Weigh In On HealthEquity
HealthEquity Stock Up 1.9%
NASDAQ HQY opened at $84.65 on Wednesday. The stock has a market cap of $7.10 billion, a PE ratio of 34.41, a P/E/G ratio of 1.51 and a beta of 0.19. HealthEquity has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The business has a 50 day moving average price of $81.98 and a two-hundred day moving average price of $87.07. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45.
HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The firm had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The business’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts predict that HealthEquity will post 3.84 EPS for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
